Maternal exposure to cadmium (Cd) during pregnancy has been linked to
low fetal birthweight, which may be attributed to placental damage and
/or dysfunction in nutrient transport. Previous studies have suggested
that Cd is accumulated in the placenta, and that placental transport
of calcium (Ca) and zinc (Zn) is perturbed by Cd. To investigate the m
echanism of Cd perturbation of Ca transport, we used JEG-3, a human ch
oriocarcinoma cell line which exhibits trophoblastic properties, to an
alyse Cd effects in vitro. Treatment with Cd at low, physiologically r
elevant concentrations (e.g. 0.04 mu M) did not result in obvious chan
ges in cell morphology or integrity, whereas higher concentrations (gr
eater than or equal to 0.16 mu M) affected cell integrity. With lower
concentrations of Cd treatment for 24 h, activities of cellular Ca upt
ake and transport, and Ca2+ binding were decreased, and intracellular
[Ca2+] ([Ca2+]i) profile was also altered; however, membrane-associate
d Ca2+-activated ATPase activity remained relatively unchanged. Intere
stingly, cellular Ca uptake activity was unaffected by short-term (30
min) Cd pretreatment. The 24-h Cd treatment also resulted in elevated
expression of the metal-binding protein, metallothionein, whereas the
expression of a trophoblast-specific cytosolic Ca2+-binding protein (H
CaBP) was drastically reduced. These results strongly suggest that Cd
exposure significantly compromises the Ca handling ability of trophobl
astic cells; this effect is probably not due to perturbations in Ca ch
annel or membrane Ca pump activities, but rather a consequence of alte
rations in subcellular, cytosolic Ca2+ binding activities. (C) 1997 W.
B. Saunders Company Ltd.